GlassScriptPhysician profile
William Bradfield
NPI 1932145216
$370.40
in general payments reported to CMS, 2019-2025
11 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.04 · 2023: $69.93 · 2024: $24.52 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $49.39 | 2025 | Zurzuvae |
| Organon LLC | $48.56 | 2023-2025 | Nexplanon, Jada System |
| Pfizer INC. | $43.48 | 2022-2023 | |
| Coopersurgical, INC. | $40.02 | 2024-2025 | Summit Doppler, Sos |
| Mimedx Group, INC. | $32.31 | 2025 | |
| Recordati_rare_diseases_inc. | $31.10 | 2025 | Isturisa |
| Optumhealth Care Solutions, LLC | $28.08 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Supernus Pharmaceuticals, INC. | $27.59 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $24.30 | 2025 | Myosure Tissue Removal Device |
| Sanofi-Aventis U.S. LLC | $23.82 | 2025 | |
| Exeltis, USA INC. | $21.75 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bradfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.